Skip to main content
. Author manuscript; available in PMC: 2009 Jun 16.
Published in final edited form as: Bioorg Med Chem Lett. 2007 May 16;17(15):4316–4319. doi: 10.1016/j.bmcl.2007.05.026

Table 1.

Anti-HIV data of compounds 3a–c in acutely infected H9 lymphocytes

Compound IC50 (μM)a EC50 (μM)b TIc
3a 57.2 0.068 841
3b 54.4 0.083 659
3cd >39.4 <0.39 >100
DCKe >16.1 0.049 >328
4-Me DCKe >38.9 0.0059 >6,600
AZT 500 0.0137 36,520
a

Concentration that inhibits uninfected H9 cell growth by 50%.

b

Concentration that inhibits viral replication by 50%.

c

TI = therapeutic index IC50/EC50.

d

More precise data could not be determined due to solubility problems.

e

The data for DCK and 4-methyl DCK were cited from Ref. 8. EC50 and TI values for DCK and 4-methyl DCK were 2.56 × 10−4 μM, 1.83 × 10−6 μM, and 1.37 × 105, 6.89 × 107, respectively, in previous screenings, using a different methodology, and publications.1